Last reviewed · How we verify

NCT02953613: LUNAR-CCTA

LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:

Terminated Last updated 10 August 2021
What this trial tests

trial testing NIRS/IVUS in Coronary Artery Disease in 7 participants. Terminated before completion.

Timeline
28 April 2016
Primary endpoint
20 November 2017
20 November 2017

Quick facts

Lead sponsorCorewell Health East
StatusTerminated
Study typeOBSERVATIONAL
Enrollment7
Start date28 April 2016
Primary completion20 November 2017
Estimated completion20 November 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Corewell Health East — full company profile →

Who can join

18 and older, any sex, with Coronary Artery Disease or Atherosclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to correlate both plaque and % lipid core content assessed by NIRS-IVUS (Imaging technique) to plaque burden and % lipid core content in coronary computerized tomographic angiography (CCTA) completed at 1 week in non-culprit coronary arteries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Corewell Health East trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02953613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing